These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8961850)

  • 1. Rapid heparin anticoagulation: use of a weight-based nomogram.
    Schaefer DC; Hufnagle J; Williams L
    Am Fam Physician; 1996 Dec; 54(8):2517-21. PubMed ID: 8961850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation.
    Shalansky KF; FitzGerald JM; Sunderji R; Traboulay SJ; O'Malley B; McCarron BI; Naiman S
    Pharmacotherapy; 1996; 16(6):1076-84. PubMed ID: 8947981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The successful application of a heparin nomogram in a community hospital.
    Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM
    Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity.
    Barletta JF; DeYoung JL; McAllen K; Baker R; Pendleton K
    Surg Obes Relat Dis; 2008; 4(6):748-53. PubMed ID: 18586569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate use of heparin. Empiric vs nomogram-based dosing.
    Gunnarsson PS; Sawyer WT; Montague D; Williams ML; Dupuis RE; Caiola SM
    Arch Intern Med; 1995 Mar; 155(5):526-32. PubMed ID: 7864708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
    Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
    Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a modified dosing weight for heparin therapy in a morbidly obese patient.
    Schwiesow SJ; Wessell AM; Steyer TE
    Ann Pharmacother; 2005 Apr; 39(4):753-6. PubMed ID: 15741422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with heparin dosing at Christchurch Hospital.
    Ward ML; Duffull SB
    N Z Med J; 1998 Jun; 111(1068):228-30. PubMed ID: 9695751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A standardized weight-based heparin protocol. Improving clinical outcomes.
    Lechner DL
    Nurs Manage; 1997 Apr; 28(4):29-32. PubMed ID: 9287775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of weight-based dosing of unfractionated heparin in obese children.
    Taylor BN; Bork SJ; Kim S; Moffett BS; Yee DL
    J Pediatr; 2013 Jul; 163(1):150-3. PubMed ID: 23414664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of implementing the weight-based heparin nomogram as a practice guideline.
    Raschke RA; Gollihare B; Peirce JC
    Arch Intern Med; 1996 Aug 12-26; 156(15):1645-9. PubMed ID: 8694662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the standard pediatric unfractionated heparin dosing protocol.
    Al Obary EE; Al-Jazairi AS; Zaghloul IM; Saleh MM; Al Musa AS; Al-Halees Z
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):153-9. PubMed ID: 22499962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center.
    Balcezak TJ; Krumholz HM; Getnick GS; Vaccarino V; Lin ZQ; Cadman EC
    Am J Manag Care; 2000 Mar; 6(3):329-38. PubMed ID: 10977433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of low-molecular-weight heparin to bridge therapy in obese patients and in patients with renal dysfunction.
    George-Phillips KL; Bungard TJ
    Pharmacotherapy; 2006 Oct; 26(10):1479-90. PubMed ID: 16999658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview.
    Bernardi E; Piccioli A; Oliboni G; Zuin R; Girolami A; Prandoni P
    Thromb Haemost; 2000 Jul; 84(1):22-6. PubMed ID: 10928464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In unfractionated heparin dosing, the combination of patient age and estimated plasma volume predicts initial antifactor Xa activity better than patient weight alone.
    Rosborough TK
    Pharmacotherapy; 1998; 18(6):1217-23. PubMed ID: 9855319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit.
    Brown G; Dodek P
    Crit Care Med; 1997 Sep; 25(9):1534-8. PubMed ID: 9295828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.